The attempt to identify c-MET as a surrogate marker for different GBM subtypes was found to be ineffective in distinguishing astrocytic tumors with IDH mutation from oligodendroglial tumors and futile to diagnose GBM owing to its inconsistent expression on a case-by-case basis (Ohba et al., 2019). Here, IDH1 is linked to glioblastoma.